SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today…
Emergent’s supplemental new drug application is the first prescription-to-over-the-counter switch application in history to be granted Priority Review by the…
WASHINGTON, Dec. 2, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765,…
Maryland Manufacturing Extension Partnership joins City/County consortium to expand third Biotech Bootcamp in Frederick FREDERICK, MD. (PRWEB) DECEMBER 01, 2022 Following…